Ephedra Supplement Restriction Appropriate Under DSHEA? -Hatch to Henney
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner-nominee Jane Henney, MD, is asked to provide her views on the agency's use of adverse events data on ephedra-containing dietary supplements as a primary basis for proposed restrictions on such products in an Oct. 1 letter from Sen. Orrin Hatch (R-Utah).